Logotype for Scandinavian Medical Solutions

Scandinavian Medical Solutions (SMSMED) Investor update summary

Event summary combining transcript, slides, and related documents.

Logotype for Scandinavian Medical Solutions

Investor update summary

23 Jul, 2026

Updated financial guidance

  • Revenue guidance for FY2024/25 lowered to DKK 200-240m from DKK 240-270m.

  • EBITDA guidance reduced to DKK 11-15m from DKK 24-29m.

Rationale for guidance adjustment

  • Geopolitical instability is causing significant volatility in global markets.

  • Potential import tariffs from Europe to the US are shortening the order book horizon.

  • Increasing caution among long-term export customers is impacting demand.

  • Uncertainty regarding the USD exchange rate and customer purchasing power is affecting outlook.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more